Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malpractice | 6 | 2021 | 11 | 3.560 |
Why?
|
| Intensive Care Units | 7 | 2023 | 103 | 2.400 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2022 | 196 | 2.380 |
Why?
|
| Noninvasive Ventilation | 3 | 2023 | 11 | 2.110 |
Why?
|
| Hospitalization | 9 | 2023 | 805 | 1.540 |
Why?
|
| Retrospective Studies | 17 | 2024 | 2471 | 1.350 |
Why?
|
| Humans | 32 | 2024 | 17707 | 1.230 |
Why?
|
| Hospital Mortality | 7 | 2022 | 145 | 1.170 |
Why?
|
| Sepsis | 2 | 2023 | 70 | 0.960 |
Why?
|
| Physicians | 3 | 2021 | 135 | 0.930 |
Why?
|
| Hospices | 1 | 2024 | 2 | 0.890 |
Why?
|
| Insurance, Liability | 2 | 2020 | 2 | 0.860 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 17 | 0.840 |
Why?
|
| Pneumonia, Viral | 2 | 2021 | 55 | 0.810 |
Why?
|
| Adult | 12 | 2024 | 7658 | 0.750 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2024 | 531 | 0.720 |
Why?
|
| Thoracentesis | 1 | 2020 | 1 | 0.690 |
Why?
|
| Tracheostomy | 1 | 2020 | 2 | 0.690 |
Why?
|
| Bronchoscopy | 1 | 2020 | 8 | 0.690 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 18 | 0.690 |
Why?
|
| Critical Care Nursing | 1 | 2020 | 2 | 0.690 |
Why?
|
| Shock, Septic | 1 | 2020 | 9 | 0.680 |
Why?
|
| Aged | 10 | 2022 | 6150 | 0.680 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 14 | 0.670 |
Why?
|
| Pulmonary Infarction | 1 | 2019 | 1 | 0.670 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 1 | 2019 | 1 | 0.670 |
Why?
|
| Betacoronavirus | 1 | 2020 | 34 | 0.670 |
Why?
|
| Nephrotic Syndrome | 1 | 2019 | 5 | 0.660 |
Why?
|
| Male | 13 | 2022 | 10094 | 0.660 |
Why?
|
| Compensation and Redress | 1 | 2019 | 1 | 0.650 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 48 | 0.640 |
Why?
|
| Pulmonary Medicine | 1 | 2019 | 19 | 0.640 |
Why?
|
| Health Policy | 1 | 2020 | 118 | 0.630 |
Why?
|
| Cardiology | 1 | 2019 | 29 | 0.630 |
Why?
|
| Middle Aged | 11 | 2022 | 7976 | 0.620 |
Why?
|
| Critical Illness | 1 | 2019 | 50 | 0.610 |
Why?
|
| Patient Readmission | 1 | 2020 | 164 | 0.590 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 596 | 0.560 |
Why?
|
| Personnel Turnover | 1 | 2017 | 5 | 0.550 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 17 | 0.550 |
Why?
|
| Heart Arrest | 1 | 2017 | 34 | 0.550 |
Why?
|
| Female | 13 | 2022 | 12729 | 0.550 |
Why?
|
| Pandemics | 3 | 2024 | 286 | 0.500 |
Why?
|
| Databases, Factual | 4 | 2021 | 311 | 0.460 |
Why?
|
| United States | 5 | 2020 | 3914 | 0.460 |
Why?
|
| Oxygen | 2 | 2023 | 16 | 0.420 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 377 | 0.410 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 6 | 0.410 |
Why?
|
| Comorbidity | 3 | 2022 | 590 | 0.380 |
Why?
|
| Medical Errors | 2 | 2023 | 15 | 0.380 |
Why?
|
| Patient Safety | 2 | 2023 | 38 | 0.370 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 37 | 0.360 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 397 | 0.350 |
Why?
|
| Liability, Legal | 2 | 2020 | 4 | 0.350 |
Why?
|
| Anticoagulants | 2 | 2022 | 128 | 0.340 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 1927 | 0.320 |
Why?
|
| Internship and Residency | 2 | 2020 | 46 | 0.300 |
Why?
|
| Inpatients | 3 | 2024 | 81 | 0.300 |
Why?
|
| Time Factors | 2 | 2020 | 1095 | 0.270 |
Why?
|
| Obesity | 1 | 2012 | 841 | 0.260 |
Why?
|
| Survival Rate | 2 | 2020 | 262 | 0.260 |
Why?
|
| Risk Factors | 3 | 2023 | 3367 | 0.250 |
Why?
|
| Hospitals | 2 | 2023 | 76 | 0.240 |
Why?
|
| Patient Harm | 1 | 2023 | 1 | 0.210 |
Why?
|
| Adenocarcinoma, Sebaceous | 1 | 2002 | 1 | 0.210 |
Why?
|
| Treatment Outcome | 3 | 2022 | 1254 | 0.210 |
Why?
|
| Outpatients | 1 | 2023 | 107 | 0.190 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 22 | 0.190 |
Why?
|
| Ethanol | 1 | 2022 | 22 | 0.190 |
Why?
|
| Skin Neoplasms | 1 | 2002 | 57 | 0.190 |
Why?
|
| Benzodiazepines | 1 | 2022 | 29 | 0.190 |
Why?
|
| Clinical Deterioration | 1 | 2021 | 5 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 137 | 0.180 |
Why?
|
| Surgery, Oral | 1 | 2020 | 1 | 0.180 |
Why?
|
| Dentistry | 1 | 2020 | 4 | 0.180 |
Why?
|
| Adolescent | 3 | 2019 | 3671 | 0.170 |
Why?
|
| Insurance Claim Reporting | 1 | 2020 | 7 | 0.170 |
Why?
|
| Obstetrics | 1 | 2020 | 21 | 0.170 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 12 | 0.170 |
Why?
|
| Operating Rooms | 1 | 2020 | 3 | 0.170 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 10 | 0.170 |
Why?
|
| Gynecology | 1 | 2020 | 22 | 0.170 |
Why?
|
| Mechanical Thrombolysis | 1 | 2019 | 1 | 0.170 |
Why?
|
| California | 3 | 2021 | 2327 | 0.170 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 60 | 0.170 |
Why?
|
| Regression Analysis | 1 | 2020 | 296 | 0.160 |
Why?
|
| Lacerations | 1 | 2019 | 1 | 0.160 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 146 | 0.160 |
Why?
|
| Internal Medicine | 1 | 2019 | 20 | 0.160 |
Why?
|
| Medicare | 1 | 2020 | 199 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 561 | 0.150 |
Why?
|
| Critical Care | 1 | 2019 | 70 | 0.150 |
Why?
|
| Length of Stay | 1 | 2019 | 182 | 0.150 |
Why?
|
| Health Maintenance Organizations | 1 | 2020 | 414 | 0.150 |
Why?
|
| Risk Assessment | 1 | 2023 | 1106 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 179 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2021 | 1287 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1117 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2019 | 241 | 0.140 |
Why?
|
| Surgery Department, Hospital | 1 | 2017 | 3 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2017 | 216 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 260 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 2589 | 0.110 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 1 | 0.100 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 3 | 0.100 |
Why?
|
| Young Adult | 1 | 2019 | 2450 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 58 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2022 | 68 | 0.100 |
Why?
|
| Child, Preschool | 1 | 2012 | 1417 | 0.080 |
Why?
|
| Neoplasms | 1 | 2012 | 442 | 0.070 |
Why?
|
| Child | 1 | 2012 | 2481 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 14 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2022 | 12 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 12 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 44 | 0.050 |
Why?
|
| Autopsy | 1 | 2021 | 15 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 107 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2021 | 81 | 0.050 |
Why?
|
| APACHE | 1 | 2021 | 11 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2022 | 189 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 1218 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 448 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 248 | 0.040 |
Why?
|
| Alcoholism | 1 | 2022 | 332 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1269 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 656 | 0.030 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->